I'd suggest just some profit taking, especially given Cann has recently placed $60m to instos at $2.50. Others in the space aren't off so sharply, some even up, and for the first time in a long time AC8 has edged ahead on market cap. Given CAN's stronger position/first mover advantage and outstanding cash balance, I'd suggest it will recover, or maybe others will come back to meet it.
